Zdrowie i gospodarka · 17/11/2017
FDA Releases Draft Guidance on Evaluation of Devices Used with Regenerative Medicine Advanced Therapies
The US Food and Drug Administration (FDA) has made available a draft document outlining its approach to evaluating devices used in regenerative medicine therapies, with the goal of simplifying and streamlining regulatory requirements for device manufacturers and developers.